FDA: Shingrix Vaccine To Warn Of Association With Guillain-Barre Syndrome
SILVER SPRING, Md. — The Food and Drug Administration on March 24 required GlaxoSmithKline to add a warning to the label of the company’s Shingrix shingles vaccine to warn of an...To view the full article, register now.
Already a subscriber? Click here to view full article